Healthcare. Agency.

It is an extraordinary time to work in healthcare. There’s real transformation happening — and transformation is not a word I use lightly. Real solutions to real problems that we couldn’t solve a decade ago. Patients living with Parkinson’s disease being given a boot that helps them walk when they freeze. Children with nonverbal autism being given ways to communicate. These are not always molecules. They don’t always require a prescription. They’re not even what we would have traditionally called pharma at all.

And yet no one is really mapping where it’s going.

Every industry that got disrupted had people who saw it coming. Healthcare doesn’t have futurists in the same way. The way we work is built around quarterly earnings, regulatory timelines, clinical cycles — and there’s no budget line, at least on the communications side, for “what if everything changes.”

That absence is worth examining. Because everything is changing — for everyone inside this system.

The door we opened

Health authority has shifted. It’s moved away from institutions, away from doctors, toward influencers, communities, algorithms, and gut instinct. Clinicians are navigating patients who arrive already decided. A whole care network — family members, caregivers, online communities — has shaped perception before anyone sets foot in the exam room.

But this didn’t happen on its own. We gave this to people. Pharma, tech platforms, health media — all had reasons to position people as the ones who own their health. What this did was open a door without seeing what was on the other side. Because when you tell people they’re empowered to take charge of their health, it means they’re empowered to believe what they’re going to believe.

So now we have misinformation at scale. Vaccine hesitancy. Wellness influencers pushing people toward choices without clinical guidance. And the forces accelerating all of it aren’t slowing down — GLP-1s reshaping entire downstream categories, AI-assisted diagnosis happening before the appointment, prediction markets entering the clinical trial space, holistic and native medicine becoming a first choice for people who have access to conventional care and are choosing otherwise.

We promised people they could take charge of their health. For many, that has never been harder.

The forces no one controls

At the same time, there are forces moving in the other direction — reducing agency, stability, and predictability for everyone. Things we can’t control.

Supply chain fragility that hasn’t been resolved. FDA volatility — regulatory standards, approval timelines, oversight priorities all in motion. Global market pressures, trade policy, tariffs reshaping launch economics in ways that aren’t fully mapped. And the system itself under strain: clinicians with less time, more administrative burden, professional authority eroding in real time.

Underneath all of it, the health/wealth gap is widening. Concierge medicine has produced a bifurcated patient population — the same drug, the same disease, two completely different lived realities, two completely different clinical relationships. Neither is a niche. Both are your market.

More agency and less stability. More information and less trust. More tools and less access. The expansion and the contraction running in two directions at once, for everyone inside the system.

What pharma actually is

Pharma is not the villain of this story. It’s also not the main character.

Pharma companies make genuinely important tools — tools that solve real problems, that extend and save lives. But those tools enter a system they don’t control, prescribed by clinicians navigating their own pressures, used by people making health decisions in ways and places the model never anticipated.

The distance between that description and the world pharma communications was built for — stable institutional authority, predictable patient behavior, the clinical relationship as the primary influence point — is where the strategic problem lives. That model still functions. It is no longer sufficient.

The obligation

You can’t do healthcare communications without thinking broadly about healthcare.

That’s a professional obligation. You have to understand what patients are navigating, what clinicians are navigating, how those realities exist all around a brand — in the spaces a campaign may never reach or even see. And none of it gets navigated consistently. Not by patients, not by clinicians. The goal of finding a clean, stable, predictable audience is a fiction the data stopped supporting a long time ago.

Which means finding the actual problem before proposing the solution. Sometimes that’s a campaign. Sometimes it’s a tool, a partnership, a reframe of what the brand is even for. The communicators who are going to matter are the ones who can look that in the eye without flinching — and who are willing to ask questions the industry hasn’t been asking.

Thinking at the level of healthcare

Breakthrough thinking in healthcare doesn’t start with comms strategy. It starts with aging populations and what it means when robots are doing things we assumed humans always would. It starts with a world in which access to health looks as unequal as access to wealth — and what that means for public health, for education, for the shape of society. It starts with what medicine looks like when the authority to practice it is no longer concentrated in the places we built for it.

Those questions belong upstream of any brief, any campaign, any brand positioning. The agencies and clients already oriented toward them are building toward a future that others are going to be surprised by.

The future of healthcare is not the future of pharma. They are related. They are not the same. And the communicators who understand the difference are the ones worth talking to.

Healthcare. Agency.

Agencies have already started signaling this shift, quietly, in the way they describe themselves. The move from “pharma advertising agency” to “healthcare communications agency” is more than rebranding — it’s an acknowledgment that the work has always been bigger than the molecule, even when the industry treated it as though it weren’t.

Healthcare. Agency. The first word is the system. The second is what’s at stake — expanding for some, contracting for others, distributed without a full accounting of the consequences, and never fully in anyone’s control.

Where does your agency stand in that future? Where do you want it to?